Advancing Cancer Therapy through Immune Monitoring
Amplimetrix provides solutions to the problem of monitoring immune response to immunotherapies in clinical trial cancer patients. In partnership with PeploBio Ltd and other leading institutes Amplimetrix has developed a suite of immunoassays that monitor anti-tumor immunity in patients enrolled into clinical trials for novel cancer therapies.
Our Services
CLINICAL TRIAL SUPPORT
All immunotherapy monitoring studies conducted at Amplimetrix in support of clinical trials are carried out to GLP standards. Our commitment to quality is evident in every assay and every project. From training, security, tracking, and redundancy your samples and data are safe with us. We’ve incorporated the following features to ensure quality of data
IMMUNE MONITORING PACKAGE
The Amplimetrix Immune Monitoring Package measures different elements of the immune system, delivering a comprehensive data set on humoral and cellular anti-tumor immunity in cancer patients. The package allows pharmaceutical companies to conduct immune monitoring studies on patients and identify those patients most likely to benefit from treatment.
MDSC ANALYSIS TOOL
The emergence of immunotherapies to treat cancer has opened many doors of opportunity. Not least among these is the development of important new immune-based biomarker assays and analysis tools for measuring and monitoring cancer patients. Amplimetrix is proud to provide access to these exciting technologies in partnership with world class academic and clinical institutions
How To Order Process
Contact Amplimetrix via phone or email US: +1 800 260 7380, Europe: +44 (0) 1483 685190, or info@amplimetrix.com
Discuss your study aims and timelines with Amplimetrix
Receive study proposal from Amplimetrix that includes aims, methods, timelines, costs, and deliverables
All parties agree on the proposal
Contract is executed and Amplimetrix receives payment for set-up costs